Early onset life-threatening myelosuppression after low dose of intravesical thiotepa (original) (raw)

Abstract

Intravesical instillation of thiotepa is a popular treatment for localized bladder carcinoma. The drug can enter the systemic circulation, and such absorption may be enhanced by extensive tumour infiltration or by a recent tumour resection. A case is reported of early onset life-threatening pancytopenia following an unusually low dose of the drug in a patient who had undergone a recent tumour resection.

380

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbassian A., Wallace D. M. Intracavitary chemotherapy of diffuse non-infiltrating papillary carcinoma of the bladder. J Urol. 1966 Oct;96(4):461–465. doi: 10.1016/S0022-5347(17)63291-9. [DOI] [PubMed] [Google Scholar]
  2. Bruce D., Edgcomb J. H. Pancytopenia and generalized sepsis following treatment of cancer of the bladder with instillations of triethylene thiophosphoramide. J Urol. 1967 Mar;97(3):482–485. doi: 10.1016/S0022-5347(17)63063-5. [DOI] [PubMed] [Google Scholar]
  3. Drew J. E., Marshall V. F. The effects of topical THIOTEPA on the recurrence rate of superficial bladder cancers. J Urol. 1968 Jun;99(6):740–743. doi: 10.1016/S0022-5347(17)62782-4. [DOI] [PubMed] [Google Scholar]
  4. Hollister D., Jr, Coleman M. Hematologic effects of intravesicular thiotepa therapy for bladder carcinoma. JAMA. 1980 Nov 7;244(18):2065–2067. [PubMed] [Google Scholar]
  5. JONES H. C., SWINNEY J. Thiotepa in the treatment of tumours of the bladder. Lancet. 1961 Sep 16;2(7203):615–618. doi: 10.1016/s0140-6736(61)90304-x. [DOI] [PubMed] [Google Scholar]
  6. Koontz W. W., Jr Intravesical chemotherapy and chemoprevention of superficial, low grade, low stage bladder carcinoma. Semin Oncol. 1979 Jun;6(2):217–219. [PubMed] [Google Scholar]
  7. Pavone-Macaluso M., Caramia G., Rizzo F. P. The use of chemotherapeutic agents in the prophylaxis of papillary bladder tumours. Urol Int. 1971;26(5):379–387. doi: 10.1159/000279745. [DOI] [PubMed] [Google Scholar]
  8. Tomiyama T. [Effects of intravesical instillation of antitumor agents on bladder cancer]. Nihon Hinyokika Gakkai Zasshi. 1972 Jul;63(7):497–518. doi: 10.5980/jpnjurol1928.63.7_497. [DOI] [PubMed] [Google Scholar]
  9. Veenema R. J., Dean A. L., Jr, Uson A. C., Roberts M., Longo F. Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors. J Urol. 1969 May;101(5):711–715. doi: 10.1016/s0022-5347(17)62408-x. [DOI] [PubMed] [Google Scholar]
  10. Wescott J. W. The prophylactic use of thio-TEPA in transitional cell carcinoma of the bladder. J Urol. 1966 Dec;96(6):913–918. doi: 10.1016/S0022-5347(17)63381-0. [DOI] [PubMed] [Google Scholar]